Our mission is to revolutionise synthetic gene synthesis to facilitate the fast-growing and exciting field of synthetic biology.
EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it has been short-listed for the 2018 Business Weekly awards. The company has been short-listed for...read more
Evonetix raises $12.3 million USD (£9 million GBP) to advance development of its highly novel gene synthesis platform
Series A round co-led by Silicon Valley investor DCVC and London-based Draper Esprit EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering an innovative approach to enable scalable and high-fidelity gene synthesis, announced today that it has completed a...read more
When serial entrepreneur Hermann Hauser talks about companies with revolutionary technology on a global scale it is wise to listen. He has started many of them and backed a good deal more with hard cash. Having ‘fathered’ ARM and steered the superchip architect into...read more
CAMBRIDGE, UK – EVONETIX LTD (‘Evonetix’), the Cambridge-based company pioneering a novel and disruptive approach to DNA synthesis, announced today the appointment of Dr Tim Brears as Chief Executive Officer. Tim previously served as Chief Executive of a number of...read more
Cambridge Consultants spin-out Evonetix poised to transform synthetic biology industry. A breakthrough in DNA synthesis has led to the creation of a new spin-out company from the stable of product design and development firm Cambridge Consultants. The joint venture,...read more